News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
265,036 Results
Type
Article (13759)
Company Profile (101)
Press Release (251176)
Section
Business (88039)
Career Advice (465)
Deals (15343)
Drug Delivery (67)
Drug Development (36602)
Employer Resources (49)
FDA (6288)
Job Trends (6196)
News (150204)
Policy (14025)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (3)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 BioForest Digital (2)
2025 Lone Star Bio Digital (4)
2026 BioCapital Standard (1)
2026 Biotech Bay Standard (1)
2026 Pharm Country Standard (1)
Academia (440)
Adcomms (6)
Allergies (32)
Alliances (23211)
ALS (36)
Alzheimer's disease (384)
Antibody-drug conjugate (ADC) (35)
Approvals (6325)
Artificial intelligence (101)
Autoimmune disease (7)
Automation (3)
Bankruptcy (149)
Best Places to Work (4370)
BIOSECURE Act (9)
Biosimilars (55)
Biotechnology (40)
Bladder cancer (18)
Brain cancer (15)
Breast cancer (74)
Cancer (573)
Cardiovascular disease (67)
Career advice (407)
Career pathing (11)
CAR-T (20)
Cell therapy (82)
Cervical cancer (4)
Clinical research (30857)
Collaboration (321)
Compensation (131)
Complete response letters (17)
COVID-19 (757)
CRISPR (19)
C-suite (112)
Cystic fibrosis (35)
Data (586)
Denatured (15)
Depression (9)
Diabetes (76)
Diagnostics (1316)
Diversity (2)
Diversity, equity & inclusion (13)
Drug discovery (55)
Drug pricing (63)
Drug shortages (12)
Duchenne muscular dystrophy (33)
Earnings (32048)
Editorial (11)
Employer branding (4)
Employer resources (43)
Events (37368)
Executive appointments (346)
FDA (6674)
Featured Employer (20)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (203)
Gene editing (37)
Generative AI (8)
Gene therapy (98)
GLP-1 (336)
Government (1285)
Grass and pollen (2)
Guidances (15)
Healthcare (3562)
Huntington's disease (4)
IgA nephropathy (9)
Immunology and inflammation (33)
Indications (12)
Infectious disease (788)
Inflammatory bowel disease (54)
Inflation Reduction Act (6)
Influenza (12)
Intellectual property (43)
Interviews (59)
IPO (5875)
IRA (29)
Job creations (2050)
Job search strategy (373)
Kidney cancer (6)
Labor market (10)
Layoffs (177)
Leadership (3)
Legal (3429)
Liver cancer (19)
Lung cancer (76)
Lymphoma (50)
Machine learning (1)
Management (16)
Manufacturing (141)
MASH (31)
Medical device (1273)
Medtech (1275)
Mergers & acquisitions (9653)
Metabolic disorders (245)
Multiple sclerosis (18)
NASH (14)
Neurodegenerative disease (21)
Neuropsychiatric disorders (6)
Neuroscience (546)
NextGen: Class of 2025 (1587)
Non-profit (593)
Northern California (667)
Now hiring (7)
Obesity (140)
Opinion (118)
Ovarian cancer (21)
Pain (49)
Pancreatic cancer (13)
Parkinson's disease (41)
Partnered (7)
Patents (102)
Patient recruitment (28)
Peanut (10)
People (28849)
Pharmaceutical (64)
Pharmacy benefit managers (11)
Phase I (8030)
Phase II (13055)
Phase III (11718)
Pipeline (381)
Podcasts (46)
Policy (58)
Postmarket research (1401)
Preclinical (3206)
Press Release (25)
Prostate cancer (44)
Psychedelics (8)
Radiopharmaceuticals (120)
Rare diseases (156)
Real estate (2633)
Recruiting (17)
Regulatory (10077)
Reports (14)
Research institute (563)
Resumes & cover letters (55)
Rett syndrome (1)
RNA editing (2)
RSV (6)
Schizophrenia (33)
Series A (35)
Series B (11)
Service/supplier (3)
Sickle cell disease (30)
Southern California (680)
Special edition (6)
Spinal muscular atrophy (77)
Sponsored (6)
Startups (1628)
State (2)
Stomach cancer (3)
Supply chain (28)
The Weekly (28)
United States (6748)
Vaccines (149)
Venture capitalists (13)
Webinars (10)
Weight loss (95)
Women's health (8)
Worklife (3)
Date
Today (32)
Last 7 days (210)
Last 30 days (879)
Last 365 days (12072)
2025 (2891)
2024 (12501)
2023 (14247)
2022 (19556)
2021 (20068)
2020 (19032)
2019 (14886)
2018 (11713)
2017 (13888)
2016 (13132)
2015 (15472)
2014 (12419)
2013 (10592)
2012 (11395)
2011 (11922)
2010 (10888)
Location
Africa (313)
Alabama (13)
Alaska (1)
Arizona (53)
Arkansas (3)
Asia (20084)
Australia (2602)
California (1612)
Canada (866)
China (226)
Colorado (65)
Connecticut (65)
Delaware (51)
Europe (39336)
Florida (299)
Georgia (35)
Idaho (9)
Illinois (181)
India (14)
Indiana (128)
Iowa (1)
Japan (85)
Kansas (55)
Kentucky (12)
Maine (2)
Maryland (245)
Massachusetts (1385)
Michigan (27)
Minnesota (89)
Missouri (23)
Montana (8)
Nebraska (6)
Nevada (7)
New Hampshire (6)
New Jersey (701)
New Mexico (7)
New York (467)
North Carolina (375)
North Dakota (2)
Northern California (667)
Ohio (48)
Oklahoma (4)
Oregon (16)
Pennsylvania (407)
Puerto Rico (8)
Rhode Island (7)
South America (501)
South Carolina (2)
Southern California (680)
Tennessee (34)
Texas (216)
Utah (33)
Virginia (69)
Washington D.C. (29)
Washington State (110)
Wisconsin (14)
265,036 Results for "aurinia pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Aurinia Pharmaceuticals to Release 2024 Fourth Quarter and Full Year Financial and Operational Results on February 27, 2025
February 21, 2025
·
1 min read
Business
Aurinia Pharmaceuticals Shareholder Urges Fellow Shareholders to Withhold Support for CEO Peter Greenleaf
Lucien Selce, who owns approximately 2.2% of the outstanding shares of Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (“Aurinia” or the “Company”), today issued the following letter to Aurinia shareholders.
June 3, 2024
·
4 min read
Press Releases
Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2024 and Provides Update on Recent Corporate Progress
February 27, 2025
·
9 min read
BioCapital
Aurinia Announces 2024 Annual General Meeting Results
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced voting results for its 2024 annual general meeting (the Meeting) of shareholders held on June 14, 2024.
June 14, 2024
·
2 min read
Business
Aurinia Pharmaceuticals Reports First Quarter 2024 Financial and Operational Results
Aurinia Pharmaceuticals Inc. issued its financial results for the first quarter ended March 31, 2024.
May 2, 2024
·
22 min read
BioCapital
Aurinia Provides Update on Proxy Statement
Aurinia Pharmaceuticals Inc. filed a supplement to the Company’s Management Information and Proxy Statement dated June 3, 2024 for its Annual General Meeting of Shareholders to be held on June 14, 2024.
June 3, 2024
·
1 min read
BioCapital
Aurinia Will Attend 2024 Jefferies Global Healthcare Conference
Aurinia Pharmaceuticals Inc. announced that it will attend the 2024 Jefferies Global Healthcare Conference in New York from June 4-6, 2024.
May 30, 2024
·
1 min read
Business
Aurinia Pharmaceuticals to Release First Quarter Financial and Operational Results on May 2, 2024
Aurinia Pharmaceuticals Inc. announced that it will release financial and operational results for the first quarter of 2024 on Thursday, May 2, 2024, before markets open.
April 15, 2024
·
1 min read
Press Releases
Aurinia Pharmaceuticals Appoints Craig Johnson to Board of Directors to Support Next Phase of Growth
November 7, 2024
·
1 min read
Press Releases
Aurinia Pharmaceuticals to Release Third Quarter Financial and Operational Results on November 7, 2024
October 30, 2024
·
1 min read
1 of 26,504
Next
